Immunopathological studies of leishmania amazonensis infection in resistant and in susceptible mice

Journal of Infectious Diseases

Volumn 201, Issue 12, 2010, Pages 1933-1940

  De Oliveira Cardoso, Flávia ^a   Da Silva Freitas De Souza, Celeste ^a   Mendes, Verônica Gonçalves ^a   Abreu Silva, Ana Lúcia ^a   Da Costa, Sylvio Celso Gonçalves ^a   Da Silva Calabresa, Kátia ^a  

^a UNIVERSIDADE ESTADUAL DO MARANHÃO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; PROTOZOON ANTIBODY;

AMASTIGOTE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; CELL COUNT; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; DISEASE MODEL; EOSINOPHIL; FEMALE; HISTOPATHOLOGY; IMMUNOASSAY; IMMUNOCYTOCHEMISTRY; IMMUNOPATHOLOGY; INFECTION SENSITIVITY; LEISHMANIASIS; LYMPH NODE; MAST CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; TISSUE INJURY; ANIMAL; BLOOD; C3H MOUSE; C57BL MOUSE; CBA MOUSE; CYTOCHEMISTRY; DBA MOUSE; DISEASE PREDISPOSITION; IMMUNOLOGY; INNATE IMMUNITY; LEISHMANIA MEXICANA; PARASITOLOGY; PATHOGENICITY; PATHOLOGY; SKIN; SKIN LEISHMANIASIS;

ANIMALS; ANTIBODIES, PROTOZOAN; DISEASE SUSCEPTIBILITY; EOSINOPHILS; FEMALE; HISTOCYTOCHEMISTRY; IMMUNITY, INNATE; LEISHMANIA MEXICANA; LEISHMANIASIS, CUTANEOUS; LYMPH NODES; MAST CELLS; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, INBRED CBA; MICE, INBRED DBA; SKIN;

EID: 77952565711     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/652870     Document Type: Article

References (48)

1. Turk JL, Belehu A. Immunological spectra in infectious diseases. In: Parasites in the immunized host: mechanisms of survival. New York, NY: Associated Scientific Publishers, 1974, 1001-1022.
2. Constance AMF, Conrad LW, Kevin CK. Severe malaria and host response: time for a paradigm shift in therapeutic strategies to improve clinical outcome. Drug Discov Today Dis Models 2007; 4(4): 207-214.
3. Matos DS, Azeredo-Coutinho RB, Schubach A, et al. Differential interferon-γ production characterizes the cytokine responses to Leishmania and Mycobacterium leprae antigens in concomitant mucocutaneous leishmaniasis and lepromatous leprosy. Clin Infect Dis 2005; 40(2):e5-e12. doi:10.1086.427069. Published 22 December 2004.
4. Handman E. Leishmaniasis: current status of vaccine development. Clin Microbiol Rev 2001; 14: 229-243. (Pubitemid 32294669)
5. Barral A, Pedral-Sampaio D, Grimaldi G Jr, et al. Leishmaniasis in Bahia, Brazil: evidence that Leishmania amazonesis produces a wide spectrum of clinical disease. Am J Trop Med Hyg 1991; 44: 536-546.
6. Calabrese KS, da Costa SC. Enhancement of Leishmania amazonensis infection in BCG non-responder mice by BCG-antigen specific vaccine. Mem Inst Oswaldo Cruz 1992; 87(suppl 1): 49-56.
7. Cupolilo SM, Souza CS, Abreu-Silva AL, Calabrese KS, Goncalves da Costa SC. Biological behavior of Leishmania (L.) amazonensis isolated from a human diffuse cutaneous leishmaniasis in inbred strains of mice. Histol Histopathol 2003; 18(4): 1059-1065.
8. Abreu-Silva AL, Calabrese KS, Tedesco RC, Mortara RA, Gonçalves da Costa SC. Central nervous system involvement in experimental infection with Leishmania (Leishmania) amazonensis. Am J Trop Med Hyg 2003; 68(6): 661-665.
9. Almeida RP, Barral-Netto M, De Jesus AM, De Freitas LA, Carvalho EM, Barral A. Biological behavior of Leishmania amazonensis isolated from humans with cutaneous, mucosal, or visceral leishmaniasis in BALB/C mice. Am J Trop Med Hyg 1996; 54(2): 178-184.
10. Abreu-Silva AL, Calabrese KS, Cupolilo SM, Cardoso FO, Souza CS, Gonçalves da Costa SC. Histopathological studies of visceralized Leishmania (Leishmania) amazonensis in mice experimentally infected. Vet Parasitol 2004; 121(3): 179-187.
11. Barral A, Badaró R, Barral-Netto M, Grimaldi G Jr, Momem H, Carvalho EM. Isolation of Leishmania mexicana amazonensis from the bone marrow in a case of American visceral leishmaniasis. Am J Trop Med Hyg 1986; 35(4): 732-734.
12. Alexander J, Russell DG. Parasite antigens, their role in protection, diagnosis and escape: the leishmaniases. Curr Top Microbiol Immunol 1985; 120: 43-67.
13. Jiaxiang J, Jiaren S, Lynn S. Infection and immunity impaired expression of inflammatory cytokines and chemokines at early stages of infection with Leishmania amazonensis. Infect Immun 2003; 71(8): 4278-4288.
14. Hoff R. A method for counting and concentrating living Trypanosoma cruzi in blood lysed with ammonium chloride. J Parasitol 1974; 60: 527-528.
15. Hodgkinson VH, Herman R, Semprevivo L. Leishmania donovani correlation among assays of amastigote viability. Exp Parasitol 1980; 50: 397-408.
16. Gonçalves da Costa S, Santos EB, Lagrange PH. Vaccination of mice against Leishmania mexicana amazonensis with microsomal fraction associated with BCG. Ann Inst Pasteur Immunol 1988; 139(2): 143-156.
17. Camargo ME, Leser PG, Leser WSP. Diagnostic information from serological tests in human toxoplasmosis. Rev Inst Med Trop São Paulo 1976; 18: 215-226.
18. Taswell C. Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis. J Immunol 1981; 126: 1614-1619. (Pubitemid 11149274)
19. Taswell C. Limiting dilution assays for the determination of immunocompetent cell frequencies. III. Validity tests for the single-hit Poisson model. J Immunol Methods 1984; 72(1): 29-40. (Pubitemid 14091991)
20. Costa AA, Abreu AL, Gomes CM, et al. Experimental model of chronic osteomyelitis caused by Leishmania (L) amazonensis. Acta Trop 2006; 98(2): 125-129.
21. Grimaldi Jr G, Tesh RB. Leishmaniasis of New World: current concepts and implication for future research. Clin Microbiol Rev 1993; 6: 230-250.
22. McMahon-Pratt D, Alexander J. Does the Leishmania major paradigm of pathogenesis and protection hold for New World cutaneous leishmaniases or the visceral disease? Immunol Rev 2004; 201: 206-224.
23. Terabe M, Wakana S, Katakura K, Onodera T, Matsumoto Y, Ito M. Influence of H2 complex and non-H2 genes on progression of cutaneous lesions in mice infected with Leishmania amazonensis. Parasitol Int 2004; 53(3): 217-221. (Pubitemid 38622623)
24. Mattel J, Behin R. Immunity: clinical and experimental. In: Peters W, Killick-Kendrics K, eds. The leishmaniasis in biology and medicine. London, England: Academic Press, 1987: 731-791.
25. Grimaldi Jr G, Soares M, Moriearty P. Tissue eosinophilia and Leishmania mexicana mexicana eosinophil interactions in murine cutaneous leishmaniasis. Parasite Immunol 1984; 6: 397-408.
26. Pompeu ML, Freitas LA, Santos MLV, Khouri M, Barral-Neto M. Granulocytes in inflammatory process of Balb/c mice infected by Leishmania amazonensis: a quantitative approach. Acta Trop 1991; 48: 185-193.
27. Pompeu ML, Freitas LA, Santos MLV, Barrai A, Barral-Neto M. Leishmania amazonensis infection: a comparison of in vivo leishmanicidal mechanisms between immunized and naive infected Balb/c mice. Exp Parasitol 1992; 74: 169-176.
28. Mehregan DR, Mehregan AH, Mehregan DA. Histologic diagnosis of cutaneous leishmaniasis. Clin Dermatol 1999; 17: 297-304.
29. Cupolilo E. Reinfecção por Leishmania (Leishmania) amazonensis no modelo murino: um estudo histopatológico e imunohistoquímico [doutorado em biologia parasitária]. Rio de Janeiro, Brazil: Instituto Oswaldo Cruz, 2002.
30. Askenase PW, Van Loveren H. Delayed-type hypersensitivity: activation of mast cells by antigen-specific T-cell factors initiates the cascade of cellular interactions. Immunol Today 1983; 4: 259-264.
31. Maurer M, Lopez Kostka S, Siebenhaar F, et al. Skin mast cells control T cell-dependent host defense in Leishmania major infections. FASEB J 2006; 20(14): 2460-2467.
32. Wershil B, Theodos C, Galii S, Titus R. Mast cells augment lesion size and persistence during experimental Leishmania major in the mouse. J Immunol 1994; 152: 4563-4571.
33. Saha B, Tonkal AMDJ, Croft S, Roy S. Mast cells at the host-pathogen interface: host-protection versus Immune evasion. Clin Exp Immunol 2004; 137: 19-23. (Pubitemid 38869773)
34. Azadeh B, Samad A, Ardehali S. Histological spectrum of cutaneous leishmaniasis due to Leishmania tropica Trans R Soc Trop Med Hyg 1985; 79: 631-636.
35. Ridley DS, Marsden PD, Cuba CC, Barreto AC. A histological classification of mucocutaneous leishmaniasis in Brazil and its clinical evaluation. Trans R Soc Trop Med Hyg 1980; 74: 508-514.
36. Abranches P, Campino L, Santos-Gomes G. Leishmaniose canina, novos conceitos de epidemiologia e imunopatologia e seus reflexos no controle da leishmaniose visceral humana. Acta Med Port 1998; 11: 871-875.
37. Lanotte G, Rioux JA, Perieres J, Vollhardt Y. Écologie des leishmaniosis dans le sud de la France. 10: les formes evolutives de la leishmaniose viscérale canine; elaboration d'une typologie bioclinique à finalité épidémiologique. Ann Parasitol Hum Comp 1979; 54: 277-295.
38. Barral A, Jesus AM, Almeida RP, et al. Evaluation of T-cell subsets in the lesion infiltrates of human cutaneous and mucocutaneous leishmaniasis. Parasite Immunol 1987; 9: 487-497. (Pubitemid 17148975)
39. Ritter U, Moll H, Laskay T, et al. Differential expression of chemokines in patients with localized and diffuse cutaneous American leishmaniasis. J Infect Dis 1996; 173(3): 699-709. (Pubitemid 26069667)
40. Olivier M, Tanner CE. Susceptibilities of macrophage populations to infection in vitro by Leishmania donovani. Infect Immun 1987; 55(2): 467-471.
41. Proudfoot L, Nikolaev AV, Feng GJ, et al. Regulation of the expression of nitric oxide synthase and leishmanicidal activity by glycoconjugates of Leishmania lipophosphoglycan in murine macrophages. Proc Natl Acad Sci U S A 1996; 93(20): 10984-10989.
42. Reiner NE, Ng W, McMaster WR. Parasite-accessory cell interactions in murine leishmaniasis. II. Leishmania donovani suppresses macrophage expression of class I and class II major histocompatibility complex gene products. J Immunol 1987; 138(6): 1926-1932.
43. Kaye PM, Rogers NJ, Curry AJ. Deficient expression of co-stimulatory molecules on Leishmania-infected macrophages. Eur J Immunol 1994; 24: 2850-2854.
44. Russo DM, Armitage RJ, Barral-Neto M, et al. Antigen-reactive γδ T cells in human leishmaniasis. J Immunol 1993; 151: 3712-3718.
45. Uyemura K, Klotz J, Pirmez C, et al. Microanatomic clonality of γδ cells in human leishmaniasis lesions. J Immunol 1992; 148: 1205-1211.
46. Rosat JP, Conceição-Silva F, Waanders GA, et al. Expansion of γδ T cells in BALB/c mice infected with Leishmania major is dependent upon Th2-type CD4 T cells. Infect Immun 1995; 63: 3000-3004.
47. Rosat JP, MacDonald HR, Louis JA. A role for γδ T cells during experimental infection of mice with Leishmania major. J Immunol 1993; 150: 550-555.
48. Mehta V, Balachandran C, Rao R, Dil SK, Indusri L. Diffuse cutaneous leishmaniasis in HIV Dermatol Online J 2009; 15(4): 9.